Blood thinner Xarelto dangers discussed by Beasley Allen attorney David Byrne

Today on the Beasley Allen Report, host Gibson Vance interviews fellow Beasley Allen attorney David Byrne on the dangers of the prescription drug Xarelto. Introduced in 2011, Xarelto is prescribed as a blood thinner to prevent blood clots and strokes. After only one year on the market, Xarelto became the 10th most reported drug to the FDA in the United States for adverse effects, and these numbers are only rising. Patients have suffered from irreversible internal bleeding that can lead to hospitalization and death. David Byrne has practiced law at Beasley Allen for more than 13 years, working first on environmental cases and now mass torts. Gibson asks Byrne about the science behind the drug and how Xarelto differs from the similar drug Coumadin. Byrne explains the lack of regulations on Xarelto and how the manufacturers market the drug in order to make it appear simpler than its competitors. Byrne recommends talking to your doctor if you are already taking Xarelto in order to have an honest discussion about concerns and alternative options.

If you have already been injured by Xarelto, he advises contacting an attorney to look into your legal rights. For more information, visit Beasley Allen online at www.BeasleyAllen.com.


We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

xarelto

Plaintiffs continue seeking justice over Xarelto...

Less than three years after Xarelto’s initial approval, the FDA issued black box warnings because of...
xarelto

New, contradictory evidence from Xarelto makers could...

There is an effective lab test to protect patients taking Xarelto, but that isn’t what jurors heard...
xarelto

Third Xarelto Trial Begins This Week

Last month, U.S. District Judge Eldon E. Fallon rejected the latest attempts by Xarelto makers to dodge...
xarelto

Recent studies confirm Xarelto bleeding risks, adverse...

There were 21,996 severe injuries reported involving anticoagulant drugs including 3,018 reported...
xarelto

Second Xarelto bellwether trial underway

The second bellwether trial involving bleeding risks with the blood thinner Xarelto is slated to begin...
xarelto

First Xarelto trial set for April; blood thinner...

The first of four bellwether trials for the Xarelto multidistrict litigation (MDL) is set to begin on...

Thanks and deep appreciation for all your work

Thanks and deep appreciation for all your work and expertise. We were able to afford many things with our settlement. Many, many thanks again and again. God bless you always.

—Thelma